Traditional Chinese medicine (TCM) manufacturers are gearing up to go public in Hong Kong, aiming to tap the market for international expansion. TCM firms have joined the queue for initial public offerings (IPOs) in the city to test foreign investors’ appetite for their shares. The latest to join the queue are Sichuan Neautus Traditional Chinese Medicine and Hong Kong-based Herb Standard. “Hong Kong will serve as our hub for capital, research and development, as well as international...